ANGIOTENSIN CONVERTING ENZYME-INHIBITION IN TISSUES FROM SPONTANEOUSLY HYPERTENSIVE RATS AFTER TREATMENT WITH CAPTOPRIL OR MK-421

This publication has 11 references indexed in Scilit:

• ANTIHYPERTENSIVE ACTIVITY OF N-[(S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALA-L-PRO (MK-421), AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR
  1981
• EFFECT OF N-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-ALA-L-PRO AND ITS ETHYL-ESTER (MK-421) ON ANGIOTENSIN CONVERTING ENZYME INVITRO AND ANGIOTENSIN-I PRESSOR-RESPONSES INVIVO
  1981
• Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain
  European Journal of Pharmacology, 1980
• Angiotensin-1-Converting Enzyme Activity in the Spontaneously Hypertensive Rat
  Experimental Biology and Medicine, 1980
• Plasma converting enzyme activity (C.E.A.) : An index of plasma levels of captopril?
  Life Sciences, 1980
• Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
  Hypertension, 1980
• Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive Rats
  Clinical Science, 1979
• Arterial Wall Renin and Renal Venous Renin in the Hypertensive Rat
  Clinical Science, 1979
• Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats
  European Journal of Pharmacology, 1977
• Kinetic properties of pulmonary angiotensin-converting enzyme. Hydrolysis of hippurylglycylglycine
  Biochimica et Biophysica Acta (BBA) - Enzymology, 1976